compared with conservative treatment, according to 2-year follow-up results from a multicenter, randomized trial.
Elective sigmoid resection and conservative treatment are options for patients, but current guidelines don't clearly define the indications for surgery, and more research was necessary to fill holes in the studies, they add. Of those 85 patients, 75 were available for assessment of quality-of-life outcomes at 12 months, and 70 were available for assessment of such outcomes at 24 months; 79 were available for evaluation of recurrence outcomes at 12 months, and 78 were available for such evaluation at 24 months.
The drop-off was likely due to the fact that 18% of patients in the conservative arm crossed over to surgery, write Susanna S. Hill, MD, with the Department of Surgery, the University of Minnesota, in Minneapolis, and Jennifer S.